Earnings ·
Pro-Dex reports $20.6M Q1 sales and $0.92 diluted EPS
PDEXPro Dex Inc
Pro-Dex announced fiscal 2027 first-quarter results ending September 30, 2026. Net sales increased 11% to $20.6 million from $18.5 million in the prior year period, driven by a $3.3 million rise in medical device revenue and contributions from its Advanced Precision Machining subsidiary. Gross profit grew 28% to $6.9 million with margins expanding to 33%. Operating income rose 13% to $3.5 million despite higher operating expenses. Net income decreased to $3.0 million, or $0.92 per diluted share, compared to $4.7 million, or $1.40 per diluted share, in the year-ago quarter, primarily due to lower unrealized gains on marketable equity investments. Pro-Dex specializes in the design and manufacture of surgical drivers and shavers for orthopedic and thoracic markets.